A comparison of semaglutide and tirzepatide Feature Semaglutide Tirzepatide FDA Approval Year 2017 (injection), 2020 (oral) 2022 Average Weight Loss ~1015% of body weight ~1520% of body weight Dosage Forms Weekly injection, oral tablet Weekly injection only Common Side Effects Nausea, vomiting, diarrhea, constipation Nausea, vomiting, diarrhea, constipation Frequency Weekly (injection), daily (oral) Weekly injection Cost (approximate) $900$1,200/month $1,000$1,300/month (Keep in mind that numbers are averages
The DAC version lasts longer, meaning fewer injections, while the non-DAC version requires more frequent dosing
10.1007/s00253-006-0440-4 Appl
During the anagen phase of hair growth, inflammatory cells such as CD8+ T cells, NK T cells, regulatory T cells, Th17 cells, and mast cells attack the hair follicles
and structural assignments have been extensively described previously 31
These include anxiety, constipation, bloating, headaches, insomnia, and autoimmune flareups, amongst others
,aspect=ignore)
